## Note
nid: 1547242137792
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3), #AK_Step2_v11::!Shelf::#Cards_AnKing_Did::2obgyn, #AK_Step2_v11::!Shelf::ObGyn::no_dupes, #AK_Step2_v11::!Shelf::ObGyn::no_dupes::only_step2, #AK_Step2_v11::#B&B::06_ObGyn::Obstetrics::16_Preterm, #AK_Step2_v11::#OME::13_Obstetrics::09_L&D_Pathology, #AK_Step2_v11::#OME_banner::Clinical::14_Obstetrics, #AK_Step2_v11::#Resources_by_rotation::ObGyn::ome::ob::l&d, #AK_Step2_v11::#Subjects::Obstetrics_&_Gynecology::02_Obstetrics_REDO::02_Delivery::Mother::Labor::Abnormal_Labor::Preterm_Labor, #AK_Step2_v11::#Subjects::Obstetrics_&_Gynecology::02_Obstetrics_REDO::02_Delivery::Mother::Labor::Abnormal_Labor::Preterm_Labor::Management, #AK_Step2_v11::#Subjects::Obstetrics_&_Gynecology::02_Obstetrics_REDO::02_Delivery::Mother::Labor::Abnormal_Labor::Preterm_Labor::Tocolytics, #AK_Step2_v11::Original_decks::Dorian::obgyn::ome::ob::l&d
markdown: false

### Text
Until what gestational age are <b>tocolytics</b> given in the
management of <b>preterm labor</b>?
<div>
  {{c1::<34 weeks}}
</div>

### Extra
<div>
  <div>
    - <i>Give along with steroids (for lung maturity)</i>
  </div>
  <div>
    <i>-</i> At >34 weeks gestation, tocolytics such as
    <b>indomethacin</b> and <b>nifedipine</b> are <font color=
    "#FC0280">not recommended</font> as the risks of indomethacin
    (oligohydramnios, closure of the ductus arteriosus) and
    nifedipine (maternal hypotension/tachycardia) outweigh the
    risks of premature delivery
  </div>
  <div>
    - <b>Indomethacin</b>, a common tocolytic, is <font color=
    "#FC0280">contraindicated after 32 weeks gestation</font> due
    to potential closure of the ductus arteriosus
  </div>
  <div>
    - Treatment for preterm labor at <34 weeks includes
    tocolytics (e.g. indomethacin, nifedipine) to postpone delivery
    and corticosteroids (e.g. betamethasone) to decrease the risk
    of neonatal respiratory distress syndrome. In addition,
    magnesium sulfate administration at <32 weeks gestation
    lowers the risk of neonatal neurological morbidities (e.g.
    cerebral palsy). Although magnesium sulfate has weak tocolytic
    properties, it is used primarily for fetal neuroprotectionin
    patients at <32 weeks gestation who are expected to deliver
    within the next 24 hours. Magnesium sulfate can be administered
    concurrently with indomethacin.
  </div>
</div><img src="paste-255314330910721.jpg">

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/obstetrics?ref=anki"><img src=
  "_OME_AnkiFlashcards_Topic_2.png"></a>
</div>

### Additional Resources


### One by one

